🔎 Trials Near Me

Home › Neuroendocrine Tumors › Arizona

Neuroendocrine Tumors clinical trials in Arizona

7 studies for Neuroendocrine Tumors are looking for participants at sites in Arizona.

Cities in Arizona

Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors

  • Mayo Clinic Hospital, Phoenix
  • The University of Arizona Cancer Center, Tucson
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT06943755

Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen

  • Banner MD Anderson Cancer Center, Gilbert
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT07087054

Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.

  • Research Facility, Phoenix
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT07165132

Project: Every Child for Younger Patients With Cancer

  • Kingman Regional Medical Center, Kingman
  • Banner Children's at Desert, Mesa
  • Phoenix Childrens Hospital, Phoenix
  • and 1 more
RecruitingObservational study
Up to age 25 · All sexes · Updated Aug 25, 2026 · NCT02402244

A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors

  • Crinetics Study Site, Phoenix
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jul 31, 2026 · NCT07129252

Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years

  • Scottsdale Medical Imaging, LLC, Scottsdale
RecruitingPhase 4
Ages 18 to 64 · All sexes · Updated Jan 22, 2026 · NCT04373564

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Scottsdale
RecruitingObservational study
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.